
Loading, please wait...

Loading, please wait...

Argentina has officially finalized its departure from the World Health Organization (WHO), marking a significant shift in its international health policy. This Argentina WHO withdrawal follows a year-long notice period initiated by President Javier Milei's administration. Foreign Minister Pablo Quirno announced the completion of the process on Tuesday. Consequently, the South American nation now aligns itself more closely with the United States in challenging global health governance. Furthermore, the government maintains that this move is essential to preserve national sovereignty and prioritize science over political interests.
The Milei administration has consistently criticized the WHO’s handling of the COVID-19 pandemic. According to official statements, the government believes the organization’s recommendations were often ineffective. Additionally, they argued that guidelines led to unnecessary economic lockdowns that hampered national growth. Because of these concerns, Argentina chose to exit the UN body to regain full control over its domestic health policies. Although the country is leaving the WHO, it remains a member of the Pan American Health Organization (PAHO). This membership allows Argentina to continue participating in regional vaccine procurement and technical cooperation. However, critics argue that the move could isolate the country from broader global research networks.
The Argentina WHO withdrawal contributes to an increasing fragmentation of international health cooperation. Historically, the WHO has spearheaded efforts to eradicate smallpox and combat infectious diseases like polio and HIV. With both the United States and Argentina withdrawing, the organization faces significant financial and political challenges. WHO Director-General Tedros Adhanom Ghebreyesus previously expressed deep regret over these developments. He warned that such actions could make the world more vulnerable to future health emergencies. Nevertheless, Argentina plans to pursue health cooperation through new bilateral agreements. This strategy reflects a growing trend of nations seeking alternative alliances outside traditional multilateral frameworks.
Q1: Why did Argentina decide to leave the WHO?
Argentina withdrew because the current administration believes the WHO prioritizes political interests over science and mishandled the COVID-19 pandemic response.
Q2: Will Argentina lose access to vaccines after the withdrawal?
While it loses direct WHO support, Argentina remains in the Pan American Health Organization (PAHO), which facilitates regional vaccine and medicine procurement.
Q3: How does this move relate to the United States?
The withdrawal mirrors the policy of U.S. President Donald Trump, who also pulled the United States out of the WHO earlier in 2026.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Argentina has finalized its withdrawal from the WHO, citing political bias. This move follows the US lead and raises concerns about global health fragmentat...
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today